Editor(s):
Reviewers:
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
The peer review history will be available very soon.
Editor(s):
Reviewers:
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
The peer review history will be available very soon.
Editor(s):
Reviewers:
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
The peer review history will be available very soon.
Editor(s):
Reviewers:
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
The peer review history will be available very soon.
Editor(s):
Reviewers:
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
The peer review history will be available very soon.
Editor(s):
Reviewers:
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
The peer review history will be available very soon.
Editor(s):
(1) Dr. Erich Cosmi, University of Padua, Italy.
Reviewers:
(1) Anubhav Chauhan, Shri Lal Bahadur Shastri Government Medical College and Hospital, India.
(2) Kumar Prafull Chandra, Chandra Diabetes Clinic, India.
(3) Emad R Issak, Ain Shams University, Egypt.
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.33/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Anubhav Chauhan, India) | File 1 | NA
Stage 2 | Peer review report_2 (Kumar Prafull Chandra, India) | File 1 | NA
Stage 2 | Peer review report_3 (Emad R Issak, Egypt) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Editor(s):
(1) Dr. Pietro Scicchitano, Hospital “F. Perinei” Altamura (Ba), Italy.
Reviewers:
(1) Robert Suslo, Wroclaw Medical University, Poland.
(2) Switbert Rwechungura Kamazima, Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania.
(3) Smeet Gala, India.
Additional Reviewers:
(1) Peter K. Uduagbamen, Bowen University Teaching Hospital, Nigeria.
Additional Reviewers: (Comments received after deadline)
(1) Abir Farouk Megahed, Mansoura Military Hospital, Egypt.
(2) A.Pramila, Alagappa University, India.
(3) Sumesh Choudhary, Institute of Kidney Diseases & Research Centre (IKDRC), Institute of Transplantation Sciences (ITS), India.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Robert Suslo, Poland) | File 1 | NA
Stage 2 | Peer review report_2 (Switbert Rwechungura Kamazima, Tanzania) | File 1 | File 2
Stage 2 | Peer review report_3 (Smeet Gala, India) | File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Editor(s):
(1) Dr. Daniele De Wrachien, Retired Professor, The State University of Milan, Italy.
Reviewers:
(1) Shahadat Hossen, Bangladesh.
(2) I Gede Ketut Adiputra, Indonesia.
Additional Reviewers:
(1) Ugochukwu Ezedigboh, Nigeria.
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.1/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Shahadat Hossen, Bangladesh) | File 1 | NA
Stage 2 | Peer review report_2 (I Gede Ketut Adiputra, Indonesia) | File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Editor(s):
(1) Dr. Farzaneh Mohamadpour, University of Sistan and Baluchestan, Iran.
Reviewers:
(1) Aymn Yaseen Sharaf Zeebaree, College of Pharmacy, Ninevah University, Iraq.
(2) Amit Gupta, I B S, Dr. B R Ambedkar University, India.
Additional Reviewers:
(1) Ernesto Cornelio Terán Portelles, Universidad de La Habana, Ecuador.
(2) M. Vijayabaskaran, JKKN College of Pharmacy, The Tamilnadu DR. M.G.R Medical University, India.
(3) Sonlimar Mangunsong, Heath Polytechnic of Palembang, Indonesia.
Additional Reviewers: (Comments received after deadline)
(1) Rajiv Dutta, Shobhit University, India.
(2) Regina Maria Silva Sousa, Brazil.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.25/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Aymn Yaseen Sharaf Zeebaree, Iraq) | File 1 | NA
Stage 2 | Peer review report_2 (Amit Gupta, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Editor(s):
(1) Dr. Manikant Tripathi, Assistant Professor, Dr. Rammanohar Lohia Avadh University, India.
Reviewers:
(1) M. Pavani, Avanthi Institute of Pharmaceutical Sciences, India.
(2) Roberto Dávila Trujillo, National Agrarian University, Perú.
(3) Ana Carla Coleone de Carvalho, São Paulo State University, UNESP, FCAV, Brazil.
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.6/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (M. Pavani, India) | File 1 | NA
Stage 2 | Peer review report_2 (Roberto Dávila Trujillo, Perú) | File 1 | NA
Stage 2 | Peer review report_3 (Ana Carla Coleone de Carvalho, Brazil) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA